Nestlé Health Science Archives - Page 2 of 2

Nestlé Health Science

Nestlé to buy Aimmune Therapeutics in $2.6bn deal

Nestlé Health Science has agreed to acquire Aimmune Therapeutics, a peanut allergy treatment maker, in a deal worth appr... Read more

September 01, 2020

Nestlé Health Science has agreed to acquire IM HealthScience, along with its brands IBgard, FDgard, Fiber Choice and REM... Read more

August 18, 2020

Childhood nutrition manufacturer Before Brands has appointed Gregory Shewchuk as its new CEO, effective immediately. Read more

December 12, 2019

Nestlé Health Science (NHSc) has become an investor in Before Brands, Inc., specialists in early childhood food allergy... Read more

September 27, 2019

Nestlé Health Science has opened a new $70m research facility, as the company aims to accelerate the development of nutr... Read more

December 03, 2018